Inventor · disambiguated record
Wen Xu
Also filed as: XU WEN · XU WEN FANG
7 granted patents·5 pending applications·6 citations·filing 2010–2021
73Inventor score
Files withCHANGZHOU JIEKAI PHARMATECH CO LTD3JS INNOPHARM SHANGHAI LTD3JS INNOMED HOLDINGS LTD2BASF SE1UNIV MARYLAND1
Top patents by PatentIndex Score
12 records- 0170US11548868B2Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereofJS INNOPHARM SHANGHAI LTD·Filed 2018·Granted Jan 10, 2023·1 cites·40 claims
- 0270US11242334B2Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereofJS INNOPHARM SHANGHAI LTD·Filed 2018·Granted Feb 8, 2022·1 cites·31 claims
- 0363US8796285B2Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereofZHANG HAILIN·Filed 2010·Granted Aug 5, 2014·3 cites·3 claims
- 0461US10696687B2Pyrazolo fused heterocyclic compounds as ERK inhibitorsCHANGZHOU JIEKAI PHARMATECH CO LTD·Filed 2015·Granted Jun 30, 2020·1 cites·9 claims
- 0555US2023039941A1Enzyme enhanced root uptake of agrochemical active compoundBASF SE·Filed 2020·Application pending·0 cites
- 0648US2017137426A1Heterocyclic compounds as axl inhibitorsCHANGZHOU JIEKAI PHARMATECH CO LTD·Filed 2014·Application pending·0 cites
- 0747US2022220128A1Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereofJS INNOPHARM SHANGHAI LTD·Filed 2020·Application pending·0 cites
- 0846US2025109118A1Heterocyclic compounds as shp2 inhibitors, compositions comprising the heterocyclic compound, and methods of use thereofJS INNOMED HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 0943US12133841B2Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereofJS INNOMED HOLDINGS LTD·Filed 2019·Granted Nov 5, 2024·0 cites·19 claims
- 1043US11246856B2Methods of treating resistant cancersUNIV MARYLAND·Filed 2018·Granted Feb 15, 2022·0 cites·8 claims
- 1135US2012121692A1Compounds and compositions comprising cdk inhibitors and methods for treating cancerXU WEN FANG·Filed 2010·Application pending·0 cites
- 1228US10479791B2Heterocyclic compounds as ERK inhibitorsCHANGZHOU JIEKAI PHARMATECH CO LTD·Filed 2015·Granted Nov 19, 2019·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Wen Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →